Literature DB >> 4992981

The complement system in rheumatoid synovitis. I. An analysis of complement component activities in rheumatoid synovial fluids.

S Ruddy, K F Austen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4992981     DOI: 10.1002/art.1780130601

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  56 in total

Review 1.  Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?

Authors:  M Peakman; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

2.  Editorial: Complement activation and disease.

Authors: 
Journal:  Br Med J       Date:  1976-02-21

3.  Studies of the action of some anti-inflammatory drugs on complement mediated immune haemolysis.

Authors:  K Whaley; D J Sloane
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

4.  Immunoglobulins and complement components in synovial fluid of patients with acute rheumatic fever.

Authors:  M Svartman; E V Potter; T Poon-King; D P Earle
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

5.  Complement (C3) metabolism in rheumatoid arthritis in relation to the disease course.

Authors:  A J Swaak; H Han; A van Rooyen; M Pillay; C E Hack
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

6.  Relationship of complement to experimental arthritis induced in rats with streptococcal cell walls.

Authors:  J H Schwab; J B Allen; S K Anderle; F Dalldorf; R Eisenberg; W J Cromartie
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

7.  Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis.

Authors:  C de Ceulaer; S Papazoglou; K Whaley
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

8.  Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases.

Authors:  P Woo; P J Lachmann; R A Harrison; N Amos; C Cooper; F S Rosen
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

9.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

10.  Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.

Authors:  G Doekes; J Schouten; A Cats; M R Daha
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.